VCYT
Veracyte, Inc.
Price Chart
Latest Quote
$50.92
+1.77 (+3.60%)
Current Price
| Previous Close | $49.15 |
| Open | $50.00 |
| Day High | $52.45 |
| Day Low | $49.42 |
| Volume | 1,768,888 |
Stock Information
| Shares Outstanding | 79.79M |
| Total Debt | $39.33M |
| Cash Equivalents | $439.06M |
| Revenue | $541.74M |
| Net Income | $88.01M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $4.06B |
| P/E Ratio | 47.15 |
| EPS (TTM) | $1.08 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.66B |
| Sales | $541.74M |
| Income | $88.01M |
| Book/sh | $16.50 |
| Cash/sh | $5.50 |
| Employees | 755 |
Financial Ratios
| Quick Ratio | 8.72 |
| Current Ratio | 9.30 |
| Debt/Eq | 2.93 |
| EPS Growth TTM | 307.40% |
Returns & Margins
| ROA | 3.76% |
| ROE | 6.93% |
| Gross Margin | 72.91% |
| Operating Margin | 16.28% |
| Profit Margin | 16.25% |
Ownership
| Insider Ownership | 0.49% |
| Institutional Ownership | 113.10% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 26.79 |
| P/S | 7.50 |
| P/B | 3.09 |
Analyst Data
| Recommendation | buy |
| Target Price | $49.10 |
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 63.03 |
| ATR | nan |
| Shares Float | 79.37M |
| Short Float | 10.90% |
| Short Ratio | 6.46 |
| Volatility | 1.98 |
| Rel Volume | 1.40 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $nan | 1,768,888 |
| 2026-06-15 | $49.15 | 1,426,600 |
| 2026-06-12 | $47.33 | 1,082,600 |
| 2026-06-11 | $47.42 | 1,042,400 |
| 2026-06-10 | $48.17 | 1,390,900 |
| 2026-06-09 | $49.24 | 1,009,600 |
| 2026-06-08 | $47.27 | 1,045,900 |
| 2026-06-05 | $48.73 | 1,168,500 |
| 2026-06-04 | $49.94 | 1,645,000 |
| 2026-06-03 | $48.69 | 1,451,600 |
| 2026-06-02 | $47.80 | 1,783,500 |
| 2026-06-01 | $48.18 | 1,527,100 |
| 2026-05-29 | $46.34 | 1,232,800 |
| 2026-05-28 | $47.99 | 999,400 |
| 2026-05-27 | $44.49 | 1,028,900 |
| 2026-05-26 | $44.21 | 940,700 |
| 2026-05-22 | $45.03 | 1,398,500 |
| 2026-05-21 | $45.19 | 1,114,600 |
| 2026-05-20 | $45.19 | 1,181,400 |
| 2026-05-19 | $41.69 | 978,500 |
| 2026-05-18 | $41.50 | 1,489,600 |
About Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
đ° Latest News
Dow Jones Futures: Techs Rebound, SpaceX Rises Despite Trump's Iran Threat; Warsh's Fed Debut Due
Investor's Business Daily âĸ 2026-06-17T12:18:32Z
This Top Biotech Has Surged. CEO Explains Key To Veracyte's Success.
Investor's Business Daily âĸ 2026-06-16T12:00:52Z
Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
Zacks âĸ 2026-06-10T12:30:03Z
How Veracyte (VCYT) Investors Can Read The Latest Unchanged Analyst Call
Simply Wall St. âĸ 2026-06-04T17:08:43Z
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
Zacks âĸ 2026-06-04T15:30:29Z
Is it Worth Retaining Veracyte Stock in Your Portfolio for Now?
Zacks âĸ 2026-05-27T15:07:00Z
Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?
Zacks âĸ 2026-05-25T15:19:00Z
Here's How Much You'd Have If You Invested $1000 in Veracyte a Decade Ago
Zacks âĸ 2026-05-25T12:30:04Z
Assessing Veracyte (VCYT) Valuation After Phase III Success For Prosigna And Decipher Cancer Tests
Simply Wall St. âĸ 2026-05-23T17:11:33Z
Statutory Profit Doesn't Reflect How Good Veracyte's (NASDAQ:VCYT) Earnings Are
Simply Wall St. âĸ 2026-05-14T11:52:28Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $135,685,000 | $127,457,000 | $106,285,000 | $97,008,000 |
| Cost Of Revenue | $154,613,000 | $147,619,000 | $131,367,000 | $120,855,000 |
| Total Revenue | $517,145,000 | $445,764,000 | $361,051,000 | $296,536,000 |
| Operating Revenue | $517,145,000 | $445,764,000 | $361,051,000 | $296,536,000 |
| Expenses | ||||
| Interest Expense | $1,000 | $2,000 | $15,000 | $198,000 |
| Total Expenses | $438,863,000 | $426,254,000 | $378,497,000 | $331,876,000 |
| Other Income Expense | $-22,804,000 | $-4,918,000 | $-66,495,000 | $-2,861,000 |
| Other Non Operating Income Expenses | $436,000 | $495,000 | $1,131,000 | $260,000 |
| Net Non Operating Interest Income Expense | $12,723,000 | $11,152,000 | $7,329,000 | $1,774,000 |
| Interest Expense Non Operating | $1,000 | $2,000 | $15,000 | $198,000 |
| Operating Expense | $284,250,000 | $278,635,000 | $247,130,000 | $211,021,000 |
| Selling And Marketing Expense | $30,956,000 | $27,772,000 | $26,604,000 | $25,302,000 |
| General And Administrative Expense | $179,993,000 | $178,272,000 | $161,115,000 | $145,458,000 |
| Rent Expense Supplemental | - | - | $8,112,000 | $5,816,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Net Interest Income | $12,723,000 | $11,152,000 | $7,329,000 | $1,774,000 |
| Interest Income | $12,724,000 | $11,154,000 | $7,344,000 | $1,972,000 |
| Normalized Income | $88,965,520 | $29,213,318 | $-8,727,019 | $-34,094,410 |
| Net Income From Continuing And Discontinued Operation | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Total Operating Income As Reported | $57,777,000 | $16,142,000 | $-85,795,000 | $-41,081,000 |
| Net Income Common Stockholders | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Net Income | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Net Income Including Noncontrolling Interests | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Net Income Continuous Operations | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Pretax Income | $68,201,000 | $25,744,000 | $-76,612,000 | $-36,427,000 |
| Special Income Charges | $-27,213,000 | $-3,368,000 | $-68,349,000 | $-3,318,000 |
| Interest Income Non Operating | $12,724,000 | $11,154,000 | $7,344,000 | $1,972,000 |
| Operating Income | $78,282,000 | $19,510,000 | $-17,446,000 | $-35,340,000 |
| Depreciation Amortization Depletion Income Statement | $2,487,000 | $3,297,000 | $2,106,000 | $2,081,000 |
| Depreciation And Amortization In Income Statement | $2,487,000 | $3,297,000 | $2,106,000 | $2,081,000 |
| Amortization Of Intangibles Income Statement | $2,487,000 | $3,297,000 | $2,106,000 | $2,081,000 |
| Gross Profit | $362,532,000 | $298,145,000 | $229,684,000 | $175,681,000 |
| Depreciation Income Statement | - | - | $3,487,000 | $2,245,000 |
| Per Share | ||||
| Diluted EPS | $0.82 | $0.31 | $-1.02 | $-0.51 |
| Basic EPS | $0.84 | $0.32 | $-1.02 | $-0.51 |
| Other | ||||
| Tax Effect Of Unusual Items | $-627,480 | $-337,682 | $-1,949,019 | $-655,410 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $112,857,000 | $54,618,000 | $18,217,000 | $-7,180,000 |
| Total Unusual Items | $-23,240,000 | $-5,413,000 | $-67,626,000 | $-3,121,000 |
| Total Unusual Items Excluding Goodwill | $-23,240,000 | $-5,413,000 | $-67,626,000 | $-3,121,000 |
| Reconciled Depreciation | $21,415,000 | $23,459,000 | $27,188,000 | $25,928,000 |
| EBITDA (Bullshit earnings) | $89,617,000 | $49,205,000 | $-49,409,000 | $-10,301,000 |
| EBIT | $68,202,000 | $25,746,000 | $-76,597,000 | $-36,229,000 |
| Diluted Average Shares | $80,573,140 | $78,163,217 | $72,644,487 | $71,549,204 |
| Basic Average Shares | $78,584,291 | $76,484,759 | $72,644,487 | $71,549,204 |
| Diluted NI Availto Com Stockholders | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Tax Provision | $1,848,000 | $1,606,000 | $-2,208,000 | $133,000 |
| Gain On Sale Of Business | $-6,708,000 | - | - | - |
| Write Off | $20,505,000 | $3,368,000 | $68,349,000 | $3,318,000 |
| Gain On Sale Of Security | $3,973,000 | $-2,045,000 | $723,000 | $197,000 |
| Amortization | $2,487,000 | $3,297,000 | $2,106,000 | $2,081,000 |
| Research And Development | $70,814,000 | $69,294,000 | $57,305,000 | $40,603,000 |
| Selling General And Administration | $210,949,000 | $206,044,000 | $187,719,000 | $170,760,000 |
| Other Gand A | $27,875,000 | $35,795,000 | $22,460,000 | $21,843,000 |
| Salaries And Wages | $152,118,000 | $142,477,000 | $138,655,000 | $123,615,000 |
| Impairment Of Capital Assets | - | $3,368,000 | $68,349,000 | $3,318,000 |
| Other Taxes | - | $-496,000 | $-571,000 | $-2,423,000 |
| Rent And Landing Fees | - | - | $8,112,000 | $5,816,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $453,274,000 | $327,865,000 | $252,525,000 | $204,443,000 |
| Total Assets | $1,406,019,000 | $1,300,035,000 | $1,114,906,000 | $1,156,422,000 |
| Total Non Current Assets | $917,643,000 | $927,768,000 | $829,285,000 | $907,786,000 |
| Other Non Current Assets | $2,550,000 | $8,525,000 | $6,847,000 | $6,167,000 |
| Goodwill And Other Intangible Assets | $856,302,000 | $848,101,000 | $791,577,000 | $870,757,000 |
| Other Intangible Assets | $89,148,000 | $102,301,000 | $88,593,000 | $174,866,000 |
| Current Assets | $488,376,000 | $372,267,000 | $285,621,000 | $248,636,000 |
| Other Current Assets | $10,281,000 | $14,551,000 | $12,661,000 | $11,469,000 |
| Inventory | $20,546,000 | $21,750,000 | $16,128,000 | $14,294,000 |
| Receivables | $44,660,000 | $46,525,000 | $40,378,000 | $44,021,000 |
| Accounts Receivable | $44,660,000 | $46,525,000 | $40,378,000 | $44,021,000 |
| Cash Cash Equivalents And Short Term Investments | $412,889,000 | $289,441,000 | $216,454,000 | $178,852,000 |
| Cash And Cash Equivalents | $362,578,000 | $239,087,000 | $216,454,000 | $154,247,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $39,654,000 | $50,737,000 | $12,630,000 | $14,718,000 |
| Long Term Debt And Capital Lease Obligation | $35,603,000 | $43,237,000 | $7,525,000 | $10,648,000 |
| Current Debt And Capital Lease Obligation | $4,051,000 | $7,500,000 | $5,105,000 | $4,070,000 |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $96,443,000 | $124,069,000 | $70,804,000 | $81,222,000 |
| Total Non Current Liabilities Net Minority Interest | $36,506,000 | $45,436,000 | $9,563,000 | $18,608,000 |
| Other Non Current Liabilities | $257,000 | $972,000 | $1,304,000 | $3,429,000 |
| Non Current Deferred Liabilities | $646,000 | $1,227,000 | $734,000 | $4,531,000 |
| Non Current Deferred Taxes Liabilities | $646,000 | $1,227,000 | $734,000 | $4,531,000 |
| Current Liabilities | $59,937,000 | $78,633,000 | $61,241,000 | $62,614,000 |
| Other Current Liabilities | $1,332,000 | $17,000,000 | $2,758,000 | $6,246,000 |
| Current Deferred Liabilities | $1,160,000 | $1,673,000 | $2,008,000 | $2,613,000 |
| Payables And Accrued Expenses | $25,935,000 | $21,865,000 | $24,940,000 | $19,048,000 |
| Payables | $4,593,000 | $8,634,000 | $12,943,000 | $11,911,000 |
| Accounts Payable | $4,593,000 | $8,634,000 | $12,943,000 | $11,911,000 |
| Equity | ||||
| Common Stock Equity | $1,309,576,000 | $1,175,966,000 | $1,044,102,000 | $1,075,200,000 |
| Total Equity Gross Minority Interest | $1,309,576,000 | $1,175,966,000 | $1,044,102,000 | $1,075,200,000 |
| Stockholders Equity | $1,309,576,000 | $1,175,966,000 | $1,044,102,000 | $1,075,200,000 |
| Gains Losses Not Affecting Retained Earnings | $-8,212,000 | $-36,090,000 | $-24,018,000 | $-31,346,000 |
| Other Equity Adjustments | $-8,212,000 | $-36,090,000 | $-24,018,000 | $-31,346,000 |
| Retained Earnings | $-377,630,000 | $-443,983,000 | $-468,121,000 | $-393,717,000 |
| Other | ||||
| Ordinary Shares Number | $79,359,005 | $77,772,678 | $73,264,738 | $71,959,454 |
| Share Issued | $79,359,005 | $77,772,678 | $73,264,738 | $71,959,454 |
| Tangible Book Value | $453,274,000 | $327,865,000 | $252,525,000 | $204,443,000 |
| Invested Capital | $1,309,576,000 | $1,175,966,000 | $1,044,102,000 | $1,075,200,000 |
| Working Capital | $428,439,000 | $293,634,000 | $224,380,000 | $186,022,000 |
| Capital Lease Obligations | $39,654,000 | $50,737,000 | $12,630,000 | $14,718,000 |
| Total Capitalization | $1,309,576,000 | $1,175,966,000 | $1,044,102,000 | $1,075,200,000 |
| Additional Paid In Capital | $1,695,339,000 | $1,655,961,000 | $1,536,168,000 | $1,500,191,000 |
| Capital Stock | $79,000 | $78,000 | $73,000 | $72,000 |
| Common Stock | $79,000 | $78,000 | $73,000 | $72,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $35,603,000 | $43,237,000 | $7,525,000 | $10,648,000 |
| Current Deferred Revenue | $1,160,000 | $1,673,000 | $2,008,000 | $2,613,000 |
| Current Capital Lease Obligation | $4,051,000 | $7,500,000 | $5,105,000 | $4,070,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $27,459,000 | $30,595,000 | $26,430,000 | $30,637,000 |
| Current Accrued Expenses | $21,342,000 | $13,231,000 | $11,997,000 | $7,137,000 |
| Goodwill | $767,154,000 | $745,800,000 | $702,984,000 | $695,891,000 |
| Net PPE | $58,791,000 | $71,142,000 | $30,861,000 | $30,862,000 |
| Accumulated Depreciation | $-43,480,000 | $-39,389,000 | $-32,860,000 | $-25,982,000 |
| Gross PPE | $102,271,000 | $110,531,000 | $63,721,000 | $56,844,000 |
| Leases | $12,377,000 | $10,625,000 | $10,306,000 | $9,740,000 |
| Construction In Progress | $0 | $106,000 | $2,465,000 | $587,000 |
| Other Properties | $73,316,000 | $81,918,000 | $37,093,000 | $34,319,000 |
| Machinery Furniture Equipment | $16,578,000 | $17,882,000 | $13,857,000 | $12,198,000 |
| Properties | $0 | $0 | $0 | $0 |
| Raw Materials | $20,546,000 | $17,876,000 | $16,128,000 | $14,294,000 |
| Other Short Term Investments | $50,311,000 | $50,354,000 | $0 | $24,605,000 |
| Other Inventories | - | $3,874,000 | - | - |
| Non Current Deferred Revenue | - | - | - | $0 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $126,630,000 | $63,809,000 | $34,261,000 | $-1,014,000 |
| Operating Activities | ||||
| Operating Cash Flow | $136,307,000 | $75,096,000 | $44,222,000 | $7,535,000 |
| Cash Flow From Continuing Operating Activities | $136,307,000 | $75,096,000 | $44,222,000 | $7,535,000 |
| Operating Gains Losses | $2,889,000 | $2,312,000 | $-825,000 | $728,000 |
| Investing Activities | ||||
| Capital Expenditure | $-9,677,000 | $-11,287,000 | $-9,961,000 | $-8,549,000 |
| Investing Cash Flow | $-9,209,000 | $-56,275,000 | $15,112,000 | $-29,387,000 |
| Cash Flow From Continuing Investing Activities | $-9,209,000 | $-56,275,000 | $15,112,000 | $-29,387,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-4,222,000 | $4,904,000 | $2,837,000 | $3,494,000 |
| Cash Flow From Continuing Financing Activities | $-4,222,000 | $4,904,000 | $2,837,000 | $3,494,000 |
| Net Other Financing Charges | $-18,304,000 | $-15,089,000 | $-6,741,000 | $-3,167,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| End Cash Position | $364,226,000 | $240,631,000 | $217,330,000 | $154,996,000 |
| Beginning Cash Position | $240,631,000 | $217,330,000 | $154,996,000 | $173,946,000 |
| Effect Of Exchange Rate Changes | $719,000 | $-424,000 | $163,000 | $-592,000 |
| Changes In Cash | $122,876,000 | $23,725,000 | $62,171,000 | $-18,358,000 |
| Proceeds From Stock Option Exercised | $14,082,000 | $19,993,000 | $9,578,000 | $7,942,000 |
| Net Investment Purchase And Sale | $3,313,000 | $-50,000,000 | $25,073,000 | $-20,838,000 |
| Sale Of Investment | $153,311,000 | $0 | $44,773,000 | $12,681,000 |
| Purchase Of Investment | $-149,998,000 | $-50,000,000 | $-19,700,000 | $-33,519,000 |
| Net Business Purchase And Sale | $-2,845,000 | $5,012,000 | $0 | $0 |
| Sale Of Business | $0 | $5,012,000 | $0 | $0 |
| Purchase Of Business | $-2,845,000 | $0 | $0 | $0 |
| Net PPE Purchase And Sale | $-9,677,000 | $-11,287,000 | $-9,961,000 | $-8,549,000 |
| Purchase Of PPE | $-9,677,000 | $-11,287,000 | $-9,961,000 | $-8,549,000 |
| Change In Working Capital | $-2,301,000 | $-20,965,000 | $-3,695,000 | $-16,381,000 |
| Change In Other Current Liabilities | $-2,480,000 | $-5,407,000 | $-4,330,000 | $-3,448,000 |
| Change In Other Current Assets | $525,000 | $-1,222,000 | $-290,000 | $-3,049,000 |
| Change In Payables And Accrued Expense | $5,277,000 | $-764,000 | $-810,000 | $-3,768,000 |
| Change In Accrued Expense | $6,316,000 | $3,541,000 | $-676,000 | $-3,920,000 |
| Change In Payable | $-1,039,000 | $-4,305,000 | $-134,000 | $152,000 |
| Change In Account Payable | $-1,039,000 | $-4,305,000 | $-134,000 | $152,000 |
| Change In Prepaid Assets | $-2,054,000 | $-1,296,000 | $-458,000 | $1,390,000 |
| Change In Inventory | $-2,861,000 | $-5,871,000 | $-1,694,000 | $-3,011,000 |
| Change In Receivables | $-708,000 | $-6,405,000 | $3,887,000 | $-4,495,000 |
| Changes In Account Receivables | $-708,000 | $-6,405,000 | $3,887,000 | $-4,495,000 |
| Other Non Cash Items | $-12,304,000 | $7,122,000 | $-1,225,000 | $3,635,000 |
| Stock Based Compensation | $43,601,000 | $36,249,000 | $33,141,000 | $26,734,000 |
| Asset Impairment Charge | $20,505,000 | $3,368,000 | $68,349,000 | $3,318,000 |
| Amortization Of Securities | $-3,270,000 | $-354,000 | $-468,000 | - |
| Deferred Tax | $-581,000 | $-233,000 | $-3,839,000 | $133,000 |
| Deferred Income Tax | $-581,000 | $-233,000 | $-3,839,000 | $133,000 |
| Depreciation Amortization Depletion | $21,415,000 | $23,459,000 | $27,188,000 | $25,928,000 |
| Depreciation And Amortization | $21,415,000 | $23,459,000 | $27,188,000 | $25,928,000 |
| Net Foreign Currency Exchange Gain Loss | $-3,834,000 | $2,110,000 | $-1,096,000 | $522,000 |
| Gain Loss On Sale Of PPE | $15,000 | $202,000 | $271,000 | $206,000 |
| Gain Loss On Sale Of Business | $6,708,000 | $0 | $0 | - |
| Net Income From Continuing Operations | $66,353,000 | $24,138,000 | $-74,404,000 | $-36,560,000 |
| Repayment Of Debt | - | $0 | $0 | $-1,281,000 |
| Interest Paid Supplemental Data | - | $0 | $0 | $9,000 |
| Income Tax Paid Supplemental Data | - | $2,236,000 | $1,697,000 | $570,000 |
| Net Issuance Payments Of Debt | - | $0 | $0 | $-1,281,000 |
| Net Long Term Debt Issuance | - | $0 | $0 | $-1,281,000 |
| Long Term Debt Payments | - | $0 | $0 | $-1,281,000 |
| Sale Of PPE | - | - | - | - |
Fetched: 2026-06-14